History
  • No items yet
midpage
55 F.4th 286
1st Cir.
2022
Read the full case

Background

  • Puerto Rico's Mi Salud (public Medicaid plan) assigned Triple‑S Salud as the exclusive insurer for the Western Region; MSO administered the provider network for MMM (a Medicare Advantage insurer).
  • Plaintiffs are urologists and urology practices in Western Puerto Rico who previously contracted with Triple‑S and some with MSO/MMM; defendants (Urologics and physician‑owned entities) allegedly became exclusive urology providers for Triple‑S and MSO, and plaintiffs lost contracts.
  • Plaintiffs sued under Sherman Act §§ 1 and 2 and parallel Commonwealth antitrust and tort laws, alleging exclusive dealing foreclosed competition and reduced quality of care.
  • The district court dismissed the amended complaint for lack of antitrust standing and for failure to state § 1 and § 2 claims; it declined supplemental jurisdiction over Commonwealth claims.
  • The First Circuit (appeal) held plaintiffs have antitrust standing and plausibly pleaded § 1 and § 2 claims as to the Triple‑S/Urologics exclusivity, but affirmed dismissal of claims against MSO/Urologics for failure to allege substantial market foreclosure; remanded and vacated dismissal of related state claims for plaintiffs challenging Triple‑S/Urologics.

Issues

Issue Plaintiff's Argument Defendant's Argument Held
Antitrust standing to sue over exclusive dealing Plaintiffs (foreclosed rivals) lost sales and allege injury to competition caused by exclusivity Defendants: customers (patients) are proper plaintiffs; no antitrust injury alleged; lack of causal link Court: Plaintiffs have antitrust standing—economic foreclosure of competitors is the kind of injury antitrust laws redress; causal link plausible
Relevant market definition / market power Plaintiffs: narrow regional submarkets (Mi Salud patients in Western PR; MMM Medicare Advantage in Western PR) Defendants: markets broader (all urology patients / other insurers), so no market power or substantial foreclosure Court: At pleading stage, plaintiffs plausibly alleged relevant submarkets; market definition is a factual inquiry for later stages
§ 1 (rule of reason) challenge to Triple‑S/Urologics exclusivity Exclusive deal foreclosed plaintiffs, reduced output and quality—showing anticompetitive effects Defendants: alleged discounts, termination clauses, and procompetitive efficiencies; no per se violation Court: Plaintiffs plausibly pleaded concerted action and anticompetitive effects; § 1 claim survives pleading stage under rule of reason framework
§§ 1 & 2 claims re MSO/Urologics exclusivity Medicare Advantage plaintiffs alleged exclusion from MMM network in Western PR Defendants: MSO/MMM do not control a substantial part of the alleged market; no substantial foreclosure alleged Court: Dismissed claims against MSO/Urologics—amended complaint fails to plead foreclosure of substantial dimensions required for § 1 or § 2 relief

Key Cases Cited

  • Bell Atl. Corp. v. Twombly, 550 U.S. 544 (pleading must state a plausible claim)
  • Brunswick Corp. v. Pueblo Bowl‑O‑Mat, Inc., 429 U.S. 477 (antitrust injury definition)
  • Stop & Shop Supermarket Co. v. Blue Cross & Blue Shield of R.I., 373 F.3d 57 (1st Cir. 2004) (exclusive‑network market definition and proof of harm)
  • Flovac, Inc. v. Airvac, Inc., 817 F.3d 849 (1st Cir. 2016) (market‑power/market‑definition threshold at pleading stage)
  • Ohio v. American Express Co., 138 S. Ct. 2274 (rule of reason requires market definition and market‑power inquiry)
  • Brown Shoe Co. v. United States, 370 U.S. 294 (submarket definition via practical indicia)
  • U.S. Healthcare, Inc. v. Healthsource, Inc., 986 F.2d 589 (1st Cir. 1993) (showing of foreclosure of substantial dimensions required to attack exclusivity)
Read the full case

Case Details

Case Name: Vazquez-Ramos v. Triple-S Salud, Inc.
Court Name: Court of Appeals for the First Circuit
Date Published: Dec 8, 2022
Citations: 55 F.4th 286; 21-1115P
Docket Number: 21-1115P
Court Abbreviation: 1st Cir.
Log In
    Vazquez-Ramos v. Triple-S Salud, Inc., 55 F.4th 286